Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects - Institut Paoli-Calmettes Accéder directement au contenu
Article Dans Une Revue British Journal of Cancer Année : 2020

Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects

Résumé

Despite striking results, clinical outcome with immune checkpoint inhibitors remains too often uncertain. This joint-project aims at generating dense longitudinal data in lung cancer patients undergoing anti-PD1 or anti-PDL1 therapy, alone or in combination with other anticancer agents. Mathematical modelling with mechanistic learning algorithms will be used next to decipher the mechanisms underlying response or resistance to immunotherapy. Ultimately, this project should help to better understand the mechanisms underlying resistance to immune checkpoint inhibitors and identify a serial of actionable items to increase the efficacy of immunotherapy.
Fichier principal
Vignette du fichier
Main text BJC comment ciccolini final.pdf (291.52 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03147110 , version 1 (19-02-2021)

Identifiants

Citer

Joseph Ciccolini, Sébastien Benzekry, Fabrice Barlesi. Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects. British Journal of Cancer, 2020, 123 (3), pp.337-338. ⟨10.1038/s41416-020-0918-3⟩. ⟨hal-03147110⟩
103 Consultations
167 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More